ahlam1399
03-09-2016, 09:04 AM
UPDATE 2-Fund manager Ackman calls Valeant ?very valuable asset?
NEW YORK, March 8 (Reuters) - Billionaire investor Bill Ackman on Tuesday called embattled drug company Valeant Pharmaceuticals a "very valuable asset" but forecast that if the company's situation does **t stabilize soon new management will be brought in or the company will be sold.
http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2.img (http://da.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/ach.img (http://adchoice.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/ach.htm)http://pi.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e205016/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=vhOYZcvg7UI:BkR5fZx0Bz0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=vhOYZcvg7UI:BkR5fZx0Bz0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=vhOYZcvg7UI:BkR5fZx0Bz0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=vhOYZcvg7UI:BkR5fZx0Bz0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=vhOYZcvg7UI:BkR5fZx0Bz0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/vhOYZcvg7UI
NEW YORK, March 8 (Reuters) - Billionaire investor Bill Ackman on Tuesday called embattled drug company Valeant Pharmaceuticals a "very valuable asset" but forecast that if the company's situation does **t stabilize soon new management will be brought in or the company will be sold.
http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/1/rc.img (http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/1/rc.htm)
http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/2/rc.img (http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/2/rc.htm)
http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/3/rc.img (http://rc.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/rc/3/rc.htm)
http://da.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2.img (http://da.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2.htm)
http://adchoice.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/ach.img (http://adchoice.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/ach.htm)http://pi.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2t.imghttp://pi2.feedsportal.com/r/247394024517/u/49/f/654213/c/35217/s/4e205016/sc/28/a2t2.imghttp://i0.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/4e205016/sc/28/mf.gif?resize=1%2C1http://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=vhOYZcvg7UI:BkR5fZx0Bz0:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=vhOYZcvg7UI:BkR5fZx0Bz0:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=vhOYZcvg7UI:BkR5fZx0Bz0:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=vhOYZcvg7UI:BkR5fZx0Bz0:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=vhOYZcvg7UI:BkR5fZx0Bz0:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/vhOYZcvg7UI